To investigate growth properties in vivo, we injected different dilutions of cancer cells to measure tumorigenicity and the corresponding endogenous expression of SOX2, OCT4, and NANOG. We chose to evaluate the ACI23 and OV90 lines, since both had consistent enrichment of cells expressing TIC markers (see Figure 4A). This evidence concerns the gene POU5F1 and cancer.